Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of dementia in people with type 2 diabetes (T2D): A populationbased cohort study

被引：0
|
作者：
Tang, Huilin [1 ]
Shaaban, C. Elizabeth [2 ]
Wu, Yonghui [1 ]
Magoc, Tanja [1 ]
Donahoo, William Troy [1 ]
DeKosky, Steven [1 ]
Bian, Jiang [1 ]
Guo, Serena Jingchuan [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
803
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [1] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [2] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [3] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
    Jasleen, Bains
    Vishal, Gupta K.
    Sameera, Malepati
    Fahad, Molla
    Brendan, O'Brien
    Deion, Santander
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [4] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study
    Tang, Huilin
    Shaaban, C. Elizabeth
    Wu, Yonghui
    Magoc, Tanja
    Donahoo, William T.
    Dekosky, Steven T.
    Bian, Jiang
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [5] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke - Reply
    Kaku, Kohei
    Lee, Jisoo
    Kaspers, Stefan
    Woerle, Hans J.
    George, Jyothis T.
    CIRCULATION JOURNAL, 2017, 81 (06) : 899 - 899
  • [6] Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    ENDOCRINE REVIEWS, 2011, 32 (04) : 515 - 531
  • [7] Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis
    Ruanpeng, Darin
    Ungprasert, Patompong
    Sangtian, Jutarat
    Harindhanavudhi, Tasma
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (06)
  • [8] Sodium Glucose Cotransporter 2 (SGLT2) Inhibition with Empagliflozin (EMPA) Reduces Microalbuminuria in Patients with Type 2 Diabetes (T2D)
    Cherney, David
    Von Eynatten, Maximilian
    Lund, Soeren
    Kaspers, Stefan
    Crowe, Suzanne
    Woerle, Hans J.
    Hach, Thomas
    DIABETES, 2014, 63 : A293 - A293
  • [9] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
    Andreea, Munteanu Madalina
    Surabhi, Swarnkar
    Razvan-Ionut, Popescu
    Lucia, Ciobotaru
    Camelia, Nicolae
    Emil, Tufanoiu
    Tiberiu, Nanea Ioan
    MEDICINA-LITHUANIA, 2023, 59 (04):
  • [10] Diabetes Leads to Sodium-Glucose Cotransporter 2 (SGLT2) Increase in the Retina
    Leley, Sameer P.
    Luo, Qianyi
    Alex, Alpha L.
    Bhatwadekar, Ashay D.
    DIABETES, 2019, 68
12345